MENU
NTRA
AS OF
Feb 4, 11:49 AM (EDT)
Price
$212.80
Change
-$14.88 (-6.54%)
Capitalization
31.75B
28 days until earnings call
Intraday BUY SELL Signals
+Compare
NTRA
Stock ticker: NASDAQ
AS OF
Feb 4, 11:49 AM (EDT)
Price
$212.80
Change
-$14.88 (-6.54%)
Capitalization
31.75B

NTRA Natera Forecast, Technical & Fundamental Analysis

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology... Show more

Industry: #Biotechnology
NTRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NTRA with price predictions
Feb 03, 2026

Aroon Indicator for NTRA shows an upward move is likely

NTRA's Aroon Indicator triggered a bullish signal on January 16, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 296 similar instances where the Aroon Indicator showed a similar pattern. In of the 296 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NTRA moved out of overbought territory on January 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NTRA as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on January 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

NTRA moved below its 50-day moving average on January 29, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NTRA broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NTRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.381) is normal, around the industry mean (12.114). P/E Ratio (0.000) is within average values for comparable stocks, (121.202). NTRA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.874). NTRA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (14.514) is also within normal values, averaging (12.571).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NTRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NTRA is expected to report earnings to fall 18.73% to -52 cents per share on March 04

Natera NTRA Stock Earnings Reports
Q4'25
Est.
$-0.52
Q3'25
Missed
by $0.27
Q2'25
Missed
by $0.12
Q1'25
Beat
by $0.14
Q4'24
Beat
by $0.08
The last earnings report on November 06 showed earnings per share of -63 cents, missing the estimate of -37 cents. With 937.16K shares outstanding, the current market capitalization sits at 31.75B.
A.I. Advisor
published General Information

General Information

a genetic testing company which develops proprietary bioinformatics-based technology

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
13011 McCallen Pass
Phone
+1 650 980-9190
Employees
3018
Web
https://www.natera.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QMAR33.21-0.03
-0.09%
FT Vest Nasdaq-100 Buffer ETF – Mar
EAOM30.39-0.07
-0.23%
iShares ESG Aware 40/60 Mod Allc ETF
HELO66.89-0.30
-0.45%
JPMorgan Hedged Equity Ldrd Ovrly ETF
SAPH35.90-1.87
-4.94%
SAP SE ADRHEDGED SAPH
CRPT13.61-0.94
-6.49%
First Trust SkyBdg Cry Idt & Dgt Eco ETF

NTRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with GH. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
-0.02%
GH - NTRA
57%
Loosely correlated
+0.75%
VCYT - NTRA
56%
Loosely correlated
+0.21%
ISRG - NTRA
53%
Loosely correlated
-1.49%
GKOS - NTRA
47%
Loosely correlated
-1.60%
TWST - NTRA
46%
Loosely correlated
+13.98%
More